These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
791 related articles for article (PubMed ID: 30864101)
1. Incidence and clinicopathologic features of H3 K27M mutations in adults with radiographically-determined midline gliomas. Schreck KC; Ranjan S; Skorupan N; Bettegowda C; Eberhart CG; Ames HM; Holdhoff M J Neurooncol; 2019 May; 143(1):87-93. PubMed ID: 30864101 [TBL] [Abstract][Full Text] [Related]
2. Diffuse high-grade gliomas with H3 K27M mutations carry a dismal prognosis independent of tumor location. Karremann M; Gielen GH; Hoffmann M; Wiese M; Colditz N; Warmuth-Metz M; Bison B; Claviez A; van Vuurden DG; von Bueren AO; Gessi M; Kühnle I; Hans VH; Benesch M; Sturm D; Kortmann RD; Waha A; Pietsch T; Kramm CM Neuro Oncol; 2018 Jan; 20(1):123-131. PubMed ID: 29016894 [TBL] [Abstract][Full Text] [Related]
3. High frequency of H3 K27M mutations in adult midline gliomas. Ebrahimi A; Skardelly M; Schuhmann MU; Ebinger M; Reuss D; Neumann M; Tabatabai G; Kohlhof-Meinecke P; Schittenhelm J J Cancer Res Clin Oncol; 2019 Apr; 145(4):839-850. PubMed ID: 30610375 [TBL] [Abstract][Full Text] [Related]
4. Transcriptomic and epigenetic profiling of 'diffuse midline gliomas, H3 K27M-mutant' discriminate two subgroups based on the type of histone H3 mutated and not supratentorial or infratentorial location. Castel D; Philippe C; Kergrohen T; Sill M; Merlevede J; Barret E; Puget S; Sainte-Rose C; Kramm CM; Jones C; Varlet P; Pfister SM; Grill J; Jones DTW; Debily MA Acta Neuropathol Commun; 2018 Nov; 6(1):117. PubMed ID: 30396367 [TBL] [Abstract][Full Text] [Related]
5. H3 K27M-mutant diffuse midline gliomas in different anatomical locations. Wang L; Li Z; Zhang M; Piao Y; Chen L; Liang H; Wei Y; Hu Z; Zhao L; Teng L; Lu D Hum Pathol; 2018 Aug; 78():89-96. PubMed ID: 29727696 [TBL] [Abstract][Full Text] [Related]
7. Diffuse Midline Gliomas with Histone H3-K27M Mutation: A Series of 47 Cases Assessing the Spectrum of Morphologic Variation and Associated Genetic Alterations. Solomon DA; Wood MD; Tihan T; Bollen AW; Gupta N; Phillips JJ; Perry A Brain Pathol; 2016 Sep; 26(5):569-80. PubMed ID: 26517431 [TBL] [Abstract][Full Text] [Related]
13. The molecular characteristics of spinal cord gliomas with or without H3 K27M mutation. Chai RC; Zhang YW; Liu YQ; Chang YZ; Pang B; Jiang T; Jia WQ; Wang YZ Acta Neuropathol Commun; 2020 Mar; 8(1):40. PubMed ID: 32228694 [TBL] [Abstract][Full Text] [Related]
14. Noninvasive assessment of H3 K27M mutational status in diffuse midline gliomas by using apparent diffusion coefficient measurements. Chen H; Hu W; He H; Yang Y; Wen G; Lv X Eur J Radiol; 2019 May; 114():152-159. PubMed ID: 31005167 [TBL] [Abstract][Full Text] [Related]
15. Selective DRD2 antagonist and ClpP agonist ONC201 in a recurrent non-midline H3 K27M-mutant glioma cohort. Odia Y; Hall MD; Cloughesy TF; Wen PY; Arrillaga-Romany I; Daghistani D; Mehta MP; Tarapore RS; Ramage SC; Allen JE Neuro Oncol; 2024 May; 26(Supplement_2):S165-S172. PubMed ID: 38386699 [TBL] [Abstract][Full Text] [Related]
17. The H3.3 K27M mutation results in a poorer prognosis in brainstem gliomas than thalamic gliomas in adults. Feng J; Hao S; Pan C; Wang Y; Wu Z; Zhang J; Yan H; Zhang L; Wan H Hum Pathol; 2015 Nov; 46(11):1626-32. PubMed ID: 26297251 [TBL] [Abstract][Full Text] [Related]
18. Tectal Low-Grade Glioma with H3 K27M Mutation. Sumi K; Shijo K; Igarashi T; Yamamuro S; Sasano M; Oshima H; Ishige T; Honma T; Yagasaki H; Yoshino A World Neurosurg; 2020 Sep; 141():91-100. PubMed ID: 32505657 [TBL] [Abstract][Full Text] [Related]
19. H3 K27M-mutant gliomas in adults vs. children share similar histological features and adverse prognosis. Kleinschmidt-DeMasters BK; Mulcahy Levy JM Clin Neuropathol; 2018; 37 (2018)(2):53-63. PubMed ID: 29393845 [TBL] [Abstract][Full Text] [Related]